Orthotopic liver transplantation and what to do during follow-up: recommendations for the practitioner.

Standard

Orthotopic liver transplantation and what to do during follow-up: recommendations for the practitioner. / Benten, Daniel; Staufer, Katharina; Sterneck, Martina.

In: NAT CLIN PRACT GASTR, Vol. 6, No. 1, 1, 2009, p. 23-36.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

APA

Vancouver

Bibtex

@article{070e13cc824b4d28833d75de81eb4315,
title = "Orthotopic liver transplantation and what to do during follow-up: recommendations for the practitioner.",
abstract = "Improvements in surgical technique and the introduction of several new immunosuppressive medications mean that outcome after orthotopic liver transplantation (OLT) has improved continuously over the past 15 years. Given the increasing longevity of patients after OLT, the recognition and prevention of long-term complications after transplantation have become ever more important. With respect to graft function, physicians responsible for the everyday care of patients following transplantation should be particularly aware of the risk of late and chronic rejection episodes and of recurrence of the underlying liver disease. The major challenge of post-transplant care is, however, how best to prevent and manage the long-term adverse effects caused by the immunosuppressive medications prescribed. Screening investigations for early diagnosis of malignancy, strict control of cardiovascular risk factors, preservation of renal function, and prevention of infections are, therefore, fundamental. This Review suggests guidelines for the management of OLT recipients to improve long-term survival, overall outcome and health-related quality of life.",
author = "Daniel Benten and Katharina Staufer and Martina Sterneck",
year = "2009",
language = "Deutsch",
volume = "6",
pages = "23--36",
number = "1",

}

RIS

TY - JOUR

T1 - Orthotopic liver transplantation and what to do during follow-up: recommendations for the practitioner.

AU - Benten, Daniel

AU - Staufer, Katharina

AU - Sterneck, Martina

PY - 2009

Y1 - 2009

N2 - Improvements in surgical technique and the introduction of several new immunosuppressive medications mean that outcome after orthotopic liver transplantation (OLT) has improved continuously over the past 15 years. Given the increasing longevity of patients after OLT, the recognition and prevention of long-term complications after transplantation have become ever more important. With respect to graft function, physicians responsible for the everyday care of patients following transplantation should be particularly aware of the risk of late and chronic rejection episodes and of recurrence of the underlying liver disease. The major challenge of post-transplant care is, however, how best to prevent and manage the long-term adverse effects caused by the immunosuppressive medications prescribed. Screening investigations for early diagnosis of malignancy, strict control of cardiovascular risk factors, preservation of renal function, and prevention of infections are, therefore, fundamental. This Review suggests guidelines for the management of OLT recipients to improve long-term survival, overall outcome and health-related quality of life.

AB - Improvements in surgical technique and the introduction of several new immunosuppressive medications mean that outcome after orthotopic liver transplantation (OLT) has improved continuously over the past 15 years. Given the increasing longevity of patients after OLT, the recognition and prevention of long-term complications after transplantation have become ever more important. With respect to graft function, physicians responsible for the everyday care of patients following transplantation should be particularly aware of the risk of late and chronic rejection episodes and of recurrence of the underlying liver disease. The major challenge of post-transplant care is, however, how best to prevent and manage the long-term adverse effects caused by the immunosuppressive medications prescribed. Screening investigations for early diagnosis of malignancy, strict control of cardiovascular risk factors, preservation of renal function, and prevention of infections are, therefore, fundamental. This Review suggests guidelines for the management of OLT recipients to improve long-term survival, overall outcome and health-related quality of life.

M3 - SCORING: Zeitschriftenaufsatz

VL - 6

SP - 23

EP - 36

IS - 1

M1 - 1

ER -